Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center
Driven By The Use of Premium-Priced Branded Agents, The HIV Drug Market Will Experience Robust Annual Growth Through 2012
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2008 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.